Background information on DR-TB -- Framework for effective control of DR-TB -- Political commitment and coordination -- Definitions : case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistant strains -- Treatment of DR-TB in special conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contacts of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antituberulosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care -- Appendices.
0
"The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs"--Publisher's description.
Guidelines for the programmatic management of drug-resistant tuberculosis.
9241547588
Antitubercular agents.
Comorbidity-- Treatment.
Highly active antiretroviral therapy.
HIV infections-- Chemotherapy.
Multidrug-resistant tuberculosis-- Chemotherapy.
Multidrug-resistant tuberculosis-- Prevention.
Antiretroviral Therapy, Highly Active.
Antitubercular Agents-- administration & dosage.
HIV Infections-- drug therapy.
Tuberculosis, Multidrug-Restant-- drug therapy
Tuberculosis, Multidrug-Restant-- prevention & control
Antitubercular agents.
Highly active antiretroviral therapy.
HIV infections-- Chemotherapy.
MEDICAL-- Oncology.
MED-- 062000
616
.
995061
RA644
.
T7
WF
310
G3468
2208
Jaramillo, Ernesto.
Great Britain., Department for International Development.
United States., Agency for International Development.